E7 TCR

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Cervical Intraepithelial NeoplasiaOropharyngeal NeoplasmsPapillomavirus Infections

Phase 1

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

WithdrawnNCT04411134

National Cancer Institute (NCI)Cervical Intraepithelial Neoplasia

Start: 2020-05-28End: 2020-07-14Updated: 2020-07-15

Phase 2

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

WithdrawnNCT04044950

National Cancer Institute (NCI)Oropharyngeal Neoplasms, Papillomavirus Infections

Start: 2019-07-29End: 2020-09-17Updated: 2020-09-22